These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 2073510)

  • 21. Prenatal factors may influence predisposition to breast cancer.
    Anbazhagan R; Gusterson BA
    Eur J Cancer; 1994; 30A(1):1-3. PubMed ID: 8142148
    [No Abstract]   [Full Text] [Related]  

  • 22. Prenatal influences and breast cancer.
    Hirayama T
    Lancet; 1993 Jan; 341(8838):185. PubMed ID: 8093794
    [No Abstract]   [Full Text] [Related]  

  • 23. Breast cancer (1).
    Harris JR; Lippman ME; Veronesi U; Willett W
    N Engl J Med; 1992 Jul; 327(5):319-28. PubMed ID: 1620171
    [No Abstract]   [Full Text] [Related]  

  • 24. Breast cancer.
    Miller BA; Feur EJ; Hankey BF
    N Engl J Med; 1992 Dec; 327(24):1756-7. PubMed ID: 1435922
    [No Abstract]   [Full Text] [Related]  

  • 25. Letter to the Editor: DDT Exposure In Utero and Breast Cancer.
    Paumgartten FJ
    J Clin Endocrinol Metab; 2015 Nov; 100(11):L104-5. PubMed ID: 26544655
    [No Abstract]   [Full Text] [Related]  

  • 26. Letter to the Editor: Comment on Statistical Adjustment in "DDT Exposure in Utero and Breast Cancer" By Cohn B.A., et al.
    Stoop P
    J Clin Endocrinol Metab; 2015 Dec; 100(12):L122. PubMed ID: 26642268
    [No Abstract]   [Full Text] [Related]  

  • 27. Prenatal influences and breast cancer.
    Stoll BA; Secreto G
    Lancet; 1992 Dec; 340(8833):1478. PubMed ID: 1360603
    [No Abstract]   [Full Text] [Related]  

  • 28. Breast cancer facts.
    J Okla State Med Assoc; 2013 Oct; 106(10):398. PubMed ID: 24404675
    [No Abstract]   [Full Text] [Related]  

  • 29. Rising incidence of breast cancer.
    Krieger N
    J Natl Cancer Inst; 1988 Mar; 80(1):2-3. PubMed ID: 3339636
    [No Abstract]   [Full Text] [Related]  

  • 30. Response to the Letter by Paumgartten F.
    Cohn BA; La Merrill M; Krigbaum NY; Yeh G; Park JS; Zimmermann L; Cirillo PM
    J Clin Endocrinol Metab; 2015 Nov; 100(11):L106. PubMed ID: 26544656
    [No Abstract]   [Full Text] [Related]  

  • 31. Response to the Letter by Stoop, P.
    Cohn BA; La Merrill M; Krigbaum NY; Yeh G; Park JS; Zimmermann L; Cirillo PM
    J Clin Endocrinol Metab; 2015 Dec; 100(12):L123-4. PubMed ID: 26642269
    [No Abstract]   [Full Text] [Related]  

  • 32. Breast cancer.
    Petrelli NJ
    Surg Oncol Clin N Am; 2014 Jul; 23(3):xiii. PubMed ID: 24882355
    [No Abstract]   [Full Text] [Related]  

  • 33. Adjustment for age at first birth in etiologic studies of breast cancer involving exposures that may affect age at first birth.
    Sharpe C
    Epidemiology; 1999 Jan; 10(1):95. PubMed ID: 9888289
    [No Abstract]   [Full Text] [Related]  

  • 34. Breast cancer statistics--1980.
    Ahmann DL
    Mayo Clin Proc; 1980 Jun; 55(6):403. PubMed ID: 7382547
    [No Abstract]   [Full Text] [Related]  

  • 35. Breast cancer risk estimation: a translational statistic for communication to the public.
    Swanson GM
    J Natl Cancer Inst; 1993 Jun; 85(11):848-9. PubMed ID: 8492310
    [No Abstract]   [Full Text] [Related]  

  • 36. Endocrine-Disrupting Chemicals and Disease Endpoints.
    Ahn C; Jeung EB
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982431
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endocrine-Disrupting Chemicals' (EDCs) Effects on Tumour Microenvironment and Cancer Progression: Emerging Contribution of RACK1.
    Buoso E; Masi M; Racchi M; Corsini E
    Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33287384
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A Combined Morphometric and Statistical Approach to Assess Nonmonotonicity in the Developing Mammary Gland of Rats in the CLARITY-BPA Study.
    Montévil M; Acevedo N; Schaeberle CM; Bharadwaj M; Fenton SE; Soto AM
    Environ Health Perspect; 2020 May; 128(5):57001. PubMed ID: 32438830
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Agrochemicals with estrogenic endocrine disrupting properties: Lessons Learned?
    Vandenberg LN; Najmi A; Mogus JP
    Mol Cell Endocrinol; 2020 Dec; 518():110860. PubMed ID: 32407980
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Perturbation of Nuclear Hormone Receptors by Endocrine Disrupting Chemicals: Mechanisms and Pathological Consequences of Exposure.
    Hall JM; Greco CW
    Cells; 2019 Dec; 9(1):. PubMed ID: 31861598
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.